Rochester, NY 6/13/2009 12:40:15 AM
Afternoon Stocks In Play - presented by WhisperFromWallStreet.com - GSB,UEC,HEB
GlobalSCAPE, Inc - Uranium Energy Corp. - Hemispherx Biopharma, Inc.
Afternoon Stocks In Play - presented by WhisperFromWallStreet.com - GSB,UEC,HEB
WhisperfromWallStreet.com is an award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, and teaching you how to become a better trader. We can now even deliver this information instantly to our "Penny Stock Alert" gadget that sits right on your Microsoft Vista or iGoogle desktop. You will know from the instant you get your confirmation email that we are different. What do you have to lose except a little time and a chance to really learn how to make money trading.
Sign up for our FREE alerts at WhisperfromWallStreet.com
---
GLOBALSCAPE INC,GSB
GlobalSCAPE, Inc. develops, distributes, and maintains secure managed file transfer software that enables individuals and business users to send data over the Internet, as well as wide-area file system, and collaboration and continuous data protection software. The company offers file transfer protocol (FTP) client programs, including CuteFTP, which permits a user to request a file from or send a file to an FTP server or host computer; and CuteFTP Pro, a program that incorporates encrypted transfers using SSL, HTTP, and SSH2, as well as S/KEY password encryption.
Last Trade: 1.78
Day's Range: 1.40 - 2.20
52wk Range: 0.50 - 2.05
Volume: 348,884
---
URANIUM ENERGY CORP,UEC
Uranium Energy Corp., a natural resource exploration company, engages in the acquisition and exploration of uranium properties in the United States. As of July 31, 2008, the company held interests in approximately 63,562.87 gross acres of leased or staked mineral properties, which included claim blocks located in Arizona, Colorado, New Mexico, Texas, Utah, and Wyoming. Uranium Energy Corp., formerly Carlin Gold, Inc., was founded in 2003 and is based in Austin, Texas.
Last Trade: 2.70
Day's Range: 2.44 - 2.90
52wk Range: 0.16 - 3.40
Volume: 1,346,197
---
HEMISPHERX BIOPHARMA,HEB
Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development, manufacture, marketing, and distribution of new drug therapies for the treatment of viral and immune based chronic disorders. The company's products include Alferon N Injection for the treatment of genital warts; and Ampligen, an experimental drug that is in human clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, HIV, renal cell carcinoma, and malignant melanoma. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and viral diseases, which is in the early stage of development; and Oragens for the treatment of viral diseases and disorders of the immune system. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Last Trade: 2.72
Day's Range: 2.41 - 2.96
52wk Range: 0.25 - 4.54
Volume: 10,357,037
---
Here are a few alerts our WhisperfromWallStreet.com subscribers enjoyed.
SPNG 1000%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up to receive free stock alerts
--
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
